Jan 15, 2016
From the Healthcare & Life Sciences Institute
In the near future, the quality, rather than the quantity, of healthcare will be incentivized, measured and rewarded. The resulting payment and delivery model will have implications for every stakeholder in the marketplace.
This paper introduces KPMG’s perspective on how healthcare organizations should evaluate the current transformative environment, which will vary widely by market. We introduce a proprietary methodology that allows healthcare organizations to evaluate the obstacles and opportunities in transitioning to value-based care in their market.